Old National Bancorp Global Blood Therapeutics, Inc. Transaction History

Old National Bancorp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Feb 17, 2023	BUY	$32.4 - $68.18 $145,281 - $305,719	4,484 New	4,484 $305,000
Q3 2022 Nov 08, 2022	SELL	$32.4 - $68.18 $226,864 - $477,396	-7,002 Reduced 60.96%	4,484 $305,000
Q2 2022 Jul 25, 2022	BUY	$22.3 - $37.39 $256,137 - $429,461	11,486 New	11,486 $367,000
Q1 2021 Apr 21, 2021	SELL	$38.94 - $50.85 $188,820 - $246,571	-4,849 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$37.65 - $63.77 $182,564 - $309,220	4,849 New	4,849 $210,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.